Paper6990976
Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites.
Chou AC and 2 others. Biochemistry, 1980. Cited by 301 papers, by iCite.
Cite this record
ConductScience Library. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Papers, record 6990976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6990976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chloroquine | Major topic |
| Heme | Major topic |
| Hemin | Major topic |
| Plasmodium berghei | Major topic |
| Animals | |
| Binding, Competitive | |
| Erythrocyte Membrane | |
| Hemoglobins | |
| Kinetics | |
| Male | |
| Mice | |
| Protein Binding | |
| Spectrophotometry |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 301 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40227011 | Hybrid Molecules as Efficient Drugs against Multidrug-Resistant Malaria Parasites. | ChemMedChem | 2025 | https://conductscience.org/library/papers/40227011 | PubMed |
| 38499199 | A pH Fingerprint Assay to Identify Inhibitors of Multiple Validated and Potential Antimalarial Drug Targets. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38499199 | PubMed |
| 37947485 | Physical Chemistry of Chloroquine Permeation through the Cell Membrane with Atomistic Detail. | J Chem Inf Model | 2023 | https://conductscience.org/library/papers/37947485 | PubMed |
| 36343283 | ln vitro inhibition of beta-hematin formation and in vivo effects of Diospyros mespiliformis and Mondia whitei methanol extracts on chloroquine-susceptible Plasmodium berghei-induced malaria in mice. | Interv Med Appl Sci | 2021 | https://conductscience.org/library/papers/36343283 | PubMed |
| 35540629 | Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development of Plasmodium falciparum at the trophozoite stage. | RSC Adv | 2019 | https://conductscience.org/library/papers/35540629 | PubMed |
| 34276369 | Pharmacological Assessment of the Antiprotozoal Activity, Cytotoxicity and Genotoxicity of Medicinal Plants Used in the Treatment of Malaria in the Greater Mpigi Region in Uganda. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34276369 | PubMed |
| 33982570 | Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development. | Acc Chem Res | 2021 | https://conductscience.org/library/papers/33982570 | PubMed |
| 31796087 | En-route to the 'elimination' of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal. | Malar J | 2019 | https://conductscience.org/library/papers/31796087 | PubMed |
| 30987583 | Leveraging the effects of chloroquine on resistant malaria parasites for combination therapies. | BMC Bioinformatics | 2019 | https://conductscience.org/library/papers/30987583 | PubMed |
| 29324251 | Potential role of Plasmodium falciparum exported protein 1 in the chloroquine mode of action. | Int J Parasitol Drugs Drug Resist | 2018 | https://conductscience.org/library/papers/29324251 | PubMed |
| 28689414 | The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization. | Langmuir | 2017 | https://conductscience.org/library/papers/28689414 | PubMed |
| 28212631 | Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria. | Malar J | 2017 | https://conductscience.org/library/papers/28212631 | PubMed |
| 27483471 | Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance. | PLoS One | 2016 | https://conductscience.org/library/papers/27483471 | PubMed |
| 26420308 | Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities. | Sci Rep | 2015 | https://conductscience.org/library/papers/26420308 | PubMed |
| 26010448 | Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin. | PLoS One | 2015 | https://conductscience.org/library/papers/26010448 | PubMed |
| 24516592 | CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infection. | PLoS One | 2014 | https://conductscience.org/library/papers/24516592 | PubMed |
| 23534360 | Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter. | Future Microbiol | 2013 | https://conductscience.org/library/papers/23534360 | PubMed |
| 23256874 | Glutathione transport: a new role for PfCRT in chloroquine resistance. | Antioxid Redox Signal | 2013 | https://conductscience.org/library/papers/23256874 | PubMed |
| 23253048 | The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor. | J Am Chem Soc | 2013 | https://conductscience.org/library/papers/23253048 | PubMed |
| 23043646 | Insights into the role of heme in the mechanism of action of antimalarials. | ACS Chem Biol | 2013 | https://conductscience.org/library/papers/23043646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6990976
GET https://conductscience.org/api/papers/v1/6990976/cited_by?page=2